Splunk Is No Slam Dunk for Investors

Even though prices have improved a little in recent days, risk still exists for a deeper decline for SPLK.

CVS Must Be Taking Some of Its Own Medicine: It Appears in Great Shape

Following its Aetna acquisition that closed back in November, CVS is positioning itself for further strength.

Let It Flow: Profit From These 4 Water Stocks

We reviewed 40 stocks that are in the business of water -- only these 4 are considered buys.

Market Is Dancing to News Headlines

What is obvious is that President Trump is growing concerned about the economic impact on the tariffs.

Square Appears Soft Here - A Dip to Buy or Avoid?

What's driving the stock's recent fall from grace with investors?

Amid Market Rotation, Where Is Amazon Stock Headed?

Our latest analysis and strategy on these FAANG shares.

Separating Quality Dividend-Paying Companies From the Wannabes: Part 2

We run Medical Properties Trust through our dividend-metric gauntlet to see whether the healthcare REIT can maintain its payout pace.

CVS Health Continues to Move Higher - New Stop Recommendation

CVS continues to move in the right direction for the bulls.

Pinterest Crafts a Good Story, but Its Charts Are Tough to Pin Down

There has been a lot of sideways action in the company's shares since it went public last spring and that pattern could continue in the weeks ahead.

Small-Caps Are Hot, Playing Ball With China, Trading Nvidia: Market Recon

The bond market is running the show? The answer would be... as much if not more than anything else... again.